Back
Inhibrx Stock Predictions
Sponsored
INBX
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
49
INBX
Inhibrx
Last Price:
34.96
Seasonality Move:
-13.85%
7 Day Trial
ALL ACCESS PASS
$
7
Billion-dollar bounty to predict China's next move
Learn moreInhibrx Stock Forecast
- Over the next 52 weeks, Inhibrx has on average historically risen by 18.4% based on the past 3 years of stock performance.
- Inhibrx has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Inhibrx Stock Undervalued?
The current Inhibrx [INBX] share price is $35.00. The Score for INBX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. - INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Inhibrx Stock Go Up Next Year?
- Over the next 52 weeks, Inhibrx has on average historically risen by 18.4% based on the past 3 years of stock performance.
Inhibrx Stock Rating
Sell
49
Inhibrx (INBX)
is a Sell
Is Inhibrx overpriced?
- Inhibrx has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Inhibrx Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
inhibrx.com
52-Week Data
52-Week High:
39.79
52-Week Low:
14.31
Prediction Charts
Market Cap:
1.66B
Price in USD:
35.00
Volume:
1.62M
Beta:
2.91
Technical Analysis
SMA50:
36.67
SMA100:
29.95
SMA200:
25.70
52-Wk Change:
55.14%
Stock Predictions
-
Is Inhibrx stock public?
Yes, Inhibrx is a publicly traded company. -
What is the Inhibrx stock quote today?
The Inhibrx stock price is 35.00 USD today. -
How to buy Inhibrx stock online?
You can buy Inhibrx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Feb-27 | 38.78 | 39.52 | 39.79 | 38.33 |
Feb-28 | 39.22 | 37.00 | 39.27 | 36.17 |
Feb-29 | 36.97 | 36.63 | 37.45 | 36.50 |
Mar-1 | 36.63 | 36.45 | 37.10 | 36.40 |
Mar-4 | 35.46 | 35.64 | 35.70 | 34.25 |
Mar-5 | 35.62 | 35.58 | 35.85 | 35.08 |
Mar-6 | 35.68 | 35.74 | 36.00 | 35.60 |
Mar-7 | 35.90 | 35.77 | 35.90 | 35.65 |
Mar-8 | 35.75 | 35.56 | 35.80 | 35.36 |
Mar-11 | 35.50 | 35.16 | 35.65 | 35.16 |
Mar-12 | 35.25 | 35.24 | 35.33 | 35.00 |
Mar-13 | 35.25 | 35.35 | 35.50 | 35.20 |
Mar-14 | 35.30 | 35.00 | 35.40 | 34.90 |
Mar-15 | 34.84 | 35.00 | 35.18 | 34.84 |
Inhibrx Earnings
Inhibrx Earnings Report: Per Share Inhibrx Earnings Q1 Q2 Q3 and Q4 last year and next year.
Inhibrx Forecast Revenue Growth
Inhibrx Stock Analysis: Historical quarterly revenues per share for Inhibrx and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $0.10 per share.
* Inhibrx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.